Text Messaging for Weight Loss
Text Messaging for Weight Loss in Primary Care Patients
Overweight and obese adults recruited from the primary care setting (n=150) will be enrolled in a 6-month randomized trial of the INTERVENTION versus CONTROL. Both groups will receive usual medical care, printed materials, and educational text messages. The INTERVENTION group will also receive personalized coaching and feedback, as well as peer support, via text message.
The investigators hypothesize that compared to those in the Control group, patients in the Intervention group will lose more weight and demonstrate more favorable changes in fruit and vegetable intake, exercise, and social support for weight loss.
研究概览
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Texas
-
Houston、Texas、美国、77030
- UT Physicians - Internal Medicine
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Approved to participate by PCP (Patients with diabetes, hypertension, or dyslipidemia will be eligible if approved by their PCP)
- Age ≥ 21 years
- Body mass index (BMI) 25 to 45 kg/m2 and weight ≤ 400 pounds
- Goal of losing weight (not just maintain weight)
- Willing to change diet, physical activity in order to lose weight.
- Currently uses text messaging in English on mobile phone
- Willing to use send and receive text messages for this study without direct compensation for cost of messages (general compensation for study participation will be provided)
- Have a scale at home for self-monitoring weight
- Fluent in English (speak, read, write)
- Commit to return for follow-up weight at 6 months regardless of amount of weight lost
Exclusion Criteria:
- Involuntary or voluntary weight loss of ≥ 5% body weight in previous 6 months
- Participating in research project involving weight loss, exercise, or dietary modification in the previous 6 months
Any of the following medical conditions which could affect weight or for which weight loss is contraindicated
- End-stage liver disease
- End-stage kidney disease
- Cancer within previous 2 years (except non-melanoma skin cancer)
- Myocardial infarction, stroke, or transient ischemic attack within previous 6 months
- Unstable angina
- Severe arthritis or other medical conditions which would prevent brisk walking
- Schizophrenia
- Hospitalization for psychiatric problems during the prior 12 months.
Current use or anticipated future use (during 6 month study) of medications that could cause weight loss:
- phentermine
- orlistat (prescription Xenical or OTC Alli)
- topiramate
- buprioprion
- exenatide (Byetta)
- liraglutide (Victoza)
- Prior bariatric surgery or plans for bariatric surgery in next 6 months
- Pregnant or breast feeding within the previous 6 months
- Planning to become pregnant in next 6 months
- Consumes > 14 alcoholic drinks per week
- Current use of illicit drugs
- Planning to move out of the area in the next 6 months
- Another member of household or a close contact is participating in the study
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Personal feedback
This arm will receive all intervention components of Active Comparator group, plus the following:
|
|
|
有源比较器:One Way Text
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in weight from baseline
大体时间:baseline and 6 months
|
Weight in a lightweight hospital gown with no shoes (calibrated digital scale)
|
baseline and 6 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in diet measured by Fruit and Vegetable Screener (NCI)
大体时间:baseline and 6 months
|
baseline and 6 months
|
|
|
Change in physical activity as measured by Paffenbarger physical activity questionnaire
大体时间:baseline and 6 months
|
baseline and 6 months
|
|
|
Change in social support as measured by Weight Management Support Inventory
大体时间:baseline and 6 months
|
A validated questionnaire with 4 domains of social support for weight control (emotional, instrumental, informational, and appraisal)
|
baseline and 6 months
|
|
Change in executive function as measured by Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A)
大体时间:baseline and 6 months
|
Measures the individual's self-rated executive functioning.
|
baseline and 6 months
|
合作者和调查者
调查人员
- 首席研究员:Kevin O. Hwang, MD、The University of Texas Health Science Center, Houston
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.